Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J de Biasi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Biomedical Engineering|November 1, 1989
Four open mammillary and catenary compartment models for pharmacokinetics studiesJ de Biasi
Journal of Biomedical Engineering|September 1, 1991
Four compartment mammillary model applied to the pharmacokinetics of a spiroarsorane administered orally to rabbitsJ de Biasi, L Rekik
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 26, 1999
Concentration at steady-state after periodic and non-uniform administration of drugY Plusquellec, J De Biasi, J Souhait
Medical Engineering & Physics|September 5, 1998
Local identifiability for two and three-compartment pharmacokinetic models with time-lagsJ A Merino, J De Biasi, Y Plusquellec, et al.
Arzneimittel-Forschung|March 1, 1996
Minimal experimental requirements for structural identifiability in linear compartmental models. The software 'IDEXMIN'J A Mérino, J de Biasi, Y Plusquellec, et al.
Arzneimittel-Forschung|November 1, 1993
Effect of drug transit time between exchange locus with plasma and sampling siteY Plusquellec, L Bousquet, J de Biasi, et al.
Journal of Pharmaceutical Sciences|May 1, 1989
A pharmacokinetic model for intraperitoneal administration of drugs: application to teniposide in humansP Canal, Y Plusquellec, E Chatelut, et al.
Revue Des Maladies Respiratoires|April 11, 2006
[Exacerbations of COPD: An audit of emergency department practice in France]O Diez, N Smail, S Pontier, et al.
Journal of Pharmaceutical Sciences|October 1, 1992
Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administrationY Plusquellec, J Barre, J de Biasi, et al.
Journal of Pharmaceutical Sciences|August 1, 1991
Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in childrenE Chatelut, H Roche, Y Plusquellec, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Biomedical Engineering|November 1, 1989
Four open mammillary and catenary compartment models for pharmacokinetics studiesJ de Biasi
Journal of Biomedical Engineering|September 1, 1991
Four compartment mammillary model applied to the pharmacokinetics of a spiroarsorane administered orally to rabbitsJ de Biasi, L Rekik
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 26, 1999
Concentration at steady-state after periodic and non-uniform administration of drugY Plusquellec, J De Biasi, J Souhait
Medical Engineering & Physics|September 5, 1998
Local identifiability for two and three-compartment pharmacokinetic models with time-lagsJ A Merino, J De Biasi, Y Plusquellec, et al.
Arzneimittel-Forschung|March 1, 1996
Minimal experimental requirements for structural identifiability in linear compartmental models. The software 'IDEXMIN'J A Mérino, J de Biasi, Y Plusquellec, et al.
Arzneimittel-Forschung|November 1, 1993
Effect of drug transit time between exchange locus with plasma and sampling siteY Plusquellec, L Bousquet, J de Biasi, et al.
Journal of Pharmaceutical Sciences|May 1, 1989
A pharmacokinetic model for intraperitoneal administration of drugs: application to teniposide in humansP Canal, Y Plusquellec, E Chatelut, et al.
Revue Des Maladies Respiratoires|April 11, 2006
[Exacerbations of COPD: An audit of emergency department practice in France]O Diez, N Smail, S Pontier, et al.
Journal of Pharmaceutical Sciences|October 1, 1992
Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administrationY Plusquellec, J Barre, J de Biasi, et al.
Journal of Pharmaceutical Sciences|August 1, 1991
Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in childrenE Chatelut, H Roche, Y Plusquellec, et al.
Pageof 1